Key result
Perioperative chemotherapy with conservative surgery achieves ~65% cure rates for localized osteosarcoma versus historical amputation.
Why the study?
Osteosarcoma is a rare highly malignant primary bone tumour with historically poor cure rates, and current treatment outcomes with chemotherapy and surgery need summarizing.
Does pre- and postoperative chemotherapy associated with surgery improve cure rates in patients with osteosarcoma compared to historical amputation?
Does pre- and postoperative chemotherapy associated with surgery improve cure rates in patients with osteosarcoma compared to historical amputation?
Modern treatment of osteosarcoma with chemotherapy and limb-salvage surgery has dramatically improved cure rates from under 10% to 60-70% for localized disease.
Answers are grounded in this paper and cite their sources.
May support chemotherapy with conservative surgery in localized osteosarcoma; leaves open randomized confirmation versus amputation.
Osteosarcoma is a primary malignant tumour of the skeleton characterised by the direct formation of immature bone or osteoid tissue by the tumour cells. The classic osteosarcoma is a rare (0.2% of all malignant tumours) highly malignant tumour, with an estimated incidence of 3 cases/million population/year. Osteosarcoma arises predominantly in the long bones and rarely in the soft tissues. The age at presentation ranges from 10 to 25 years of age. Plain radiographs, computed tomography, magnetic resonance imaging, angiography and dynamic bone scintigraphy are used for diagnosis, evaluation the extent of tumour involvement and decision of the type of operation and, if necessary, the type of reconstruction. Years ago, all patients with osteosarcoma were treated by amputation but the cure rate was under 10% and almost all patients died within a year from diagnosis. Today, for localised osteosarcoma at onset (80% of cases) treated in specialized bone tumour centres with pre- and postoperative chemotherapy associated with surgery, the percentage of patients cured varies between 60% and 70%. Surgery is conservative (limb salvage) in more than 90% of patients. Prognosis is more severe (cure rate about 30%) for tumours located in the axial skeleton and in patients with metastasis at onset.
No takes yet. Share an insight, caveat, or question.
Piero Picci (2007) conducted a review in Osteosarcoma. Pre- and postoperative chemotherapy associated with surgery vs. Amputation (historical) was evaluated on Cure rate. Pre- and postoperative chemotherapy with conservative surgery for localized osteosarcoma achieves cure rates of 60-70%, compared to historical cure rates under 10% with amputation alone.
Synapse has enriched 10 related papers. Consider them for comparative context: